NCT00092729 - An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064) | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

June 7, 2002

Primary Completion Date

December 6, 2002

Study Completion Date

December 6, 2002

Conditions

Dysmenorrhea

Interventions

DRUG

etoricoxib (MK0663)

Two etoricoxib 60 mg tablets and one naproxen sodium 550 mg placebo tablet, single-dose, following onset of moderate-to-severe pain due to primary dysmenorrhea

DRUG

Comparator: placebo (unspecified)

Two etoricoxib 60 mg placebo tablets and one naproxen sodium 550 mg placebo tablet, single-dose, following onset of moderate-to-severe pain due to primary dysmenorrhea

DRUG

Comparator: naproxen sodium

Two etoricoxib 60 mg placebo tablets and one naproxen sodium 550 mg tablet, single-dose, following onset of moderate-to-severe pain due to primary dysmenorrhea

All Listed Sponsors

lead

Organon and Co

INDUSTRY